MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

MAKE WAY FOR THE FIRST ACTIVE HEMOSTATIC POWDER

18 DECEMBER 2017

Biom’up receives FDA marketing approval  for HEMOBLAST™ Bellows, its flagship product

-Approval granted several months ahead of the initial schedule

-Launch of HEMOBLAST™ Bellows in the United States expected over the summer in 2018

Read more:

pr-18-12-17

ALL NEWS

Legal Information: HEMOBLAST™ Bellows - Implantable Medical device Class III for surgery reserved for use by qualified healthcare professionals, reimbursement depends on each country.
Read the instructions for use on the packaging carefully before use. CE0086: BSI - Manufacturer: Biom’up SA France.